Branched-chain amino acids in skeletal and cardiac muscles: a review of metabolic variations and cancer’s impact
- 1Chair and Department of Physiology and Pathophysiology, Medical University of Warsaw, Warsaw, Poland
- 2Chair and Department of Biochemistry, Medical University of Warsaw, Warsaw, Poland
Abstract
Branched-chain amino acids (BCAA) - leucine, isoleucine, and valine - serve as essential regulators of energy homeostasis, protein turnover, and nutrient signaling in striated muscle. However, their metabolic processing varies substantially across tissues. This review contrasts BCAA metabolism in skeletal versus cardiac muscle and evaluates how cancer alters it. Skeletal muscle functions as the main site for whole-body BCAA transamination and oxidation, distributing these amino acids between protein synthesis and oxidative catabolism in line with physiological needs. In comparison, the myocardium maintains low baseline BCAA oxidation, depends primarily on fatty acids and glucose, and tightly limits BCAA catabolic flux to prevent the buildup of intermediates that would undermine mitochondrial function. In malignancies, BCAA metabolism is reconfigured in a way that depends on tumor type: many tumors increase BCAA uptake and suppress catabolism in order to preserve intracellular stores, as a result maintaining mechanistic target of rapamycin complex 1 (mTORC1) signaling and supporting proliferation. Using lung, pancreatic and colorectal cancers as main examples, we outline how this tumor-driven metabolic rewiring is linked to cancer cachexia - a multi-organ syndrome in which inflammation, mitochondrial dysfunction, and impaired anabolic signaling promote muscle and cardiac wasting rather than simple substrate limitation. We describe first the mechanisms shared by skeletal and cardiac muscle, then the features specific to each tumor type, and we distinguish throughout between cardiac evidence obtained in tumor-bearing hosts and inferences extrapolated from heart failure. We conclude that interventions directed at BCAA are most reasonable early in the disease course, and only when paired with approaches that suppress inflammation and restore mitochondrial quality control. We also identify priorities for tissue-specific biomarkers and for future research.
Related
- Enhanced glucose uptake in cardiac and skeletal muscles in Danon disease results from the impaired chaperone-mediated autophagy.
- Differential localization of autolyzed calpains 1 and 2 in slow and fast skeletal muscles in the early phase of atrophy
- Myosin filaments of vertebrate skeletal and cardiac muscle are highly similar, but not identical
- Regional variations in out-of-hospital cardiac arrest outcomes after the Great East Japan Earthquake: a 16-year cohort study
- Variations in Assessment Methods of Heterogeneous Exercise Capacity Response After Cardiac Rehabilitation
BibTeX
@article{chrzanowski2026branchedchain,
title = {{Branched-chain amino acids in skeletal and cardiac muscles: a review of metabolic variations and cancer’s impact}},
author = {Julian Chrzanowski and Wojciech Graboń and Karolina Buchajska and Agnieszka Cudnoch-Jędrzejewska},
journal = {Frontiers in Physiology},
year = {2026},
month = oct,
doi = {10.3389/fphys.2026.1943433},
url = {https://doi.org/10.3389/fphys.2026.1943433},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Branched-chain amino acids in skeletal and cardiac muscles: a review of metabolic variations and cancer’s impact
AU - Julian Chrzanowski
AU - Wojciech Graboń
AU - Karolina Buchajska
AU - Agnieszka Cudnoch-Jędrzejewska
PY - 2026
DA - 2026/10/22
JO - Frontiers in Physiology
DO - 10.3389/fphys.2026.1943433
UR - https://doi.org/10.3389/fphys.2026.1943433
AB - Branched-chain amino acids (BCAA) - leucine, isoleucine, and valine - serve as essential regulators of energy homeostasis, protein turnover, and nutrient signaling in striated muscle. However, their metabolic processing varies substantially across tissues. This review contrasts BCAA metabolism in skeletal versus cardiac muscle and evaluates how cancer alters it. Skeletal muscle functions as the main site for whole-body BCAA transamination and oxidation, distributing these amino acids between protein synthesis and oxidative catabolism in line with physiological needs. In comparison, the myocardium maintains low baseline BCAA oxidation, depends primarily on fatty acids and glucose, and tightly limits BCAA catabolic flux to prevent the buildup of intermediates that would undermine mitochondrial function. In malignancies, BCAA metabolism is reconfigured in a way that depends on tumor type: many tumors increase BCAA uptake and suppress catabolism in order to preserve intracellular stores, as a result maintaining mechanistic target of rapamycin complex 1 (mTORC1) signaling and supporting proliferation. Using lung, pancreatic and colorectal cancers as main examples, we outline how this tumor-driven metabolic rewiring is linked to cancer cachexia - a multi-organ syndrome in which inflammation, mitochondrial dysfunction, and impaired anabolic signaling promote muscle and cardiac wasting rather than simple substrate limitation. We describe first the mechanisms shared by skeletal and cardiac muscle, then the features specific to each tumor type, and we distinguish throughout between cardiac evidence obtained in tumor-bearing hosts and inferences extrapolated from heart failure. We conclude that interventions directed at BCAA are most reasonable early in the disease course, and only when paired with approaches that suppress inflammation and restore mitochondrial quality control. We also identify priorities for tissue-specific biomarkers and for future research.
SN - 1664-042X
ER -